NCT01475266 - Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Bladder Cancer

Interventions

DRUG

EO9 (Apaziquone)

4 mg/40 mL, Intravesical instillation, Single dose within 6 hours after TURBT

DRUG

Placebo

40 mL, Intravesical instillation, Single dose within 6 hours after TURBT

Trial Locations (20)

Nippon Kayaku Investigational site 103, Yokosuka

Nippon Kayaku Investigational site 107, Kashihara

Nippon Kayaku Investigational site 109, Kurashiki

Nippon Kayaku Investigational site 105, Sayama

Nippon Kayaku Investigational site 104, Hamamatsu

Nippon Kayaku Investigational site 102, Musashino

Nippon kayaku Investigational site 101, Chiba

Nippon Kayaku Investigational site 110, Fukuoka

Nippon Kayaku Investigational site 111, Fukuoka

Nippon Kayaku Investigational site 106, Nara

Nippon Kayaku Investigational site 108, Okayama

Handok Investigational site 203, Bundang

Handok Investigational site 202, Daegu

Handok Investigational site 209, Hwasun

Handok Investigational site 201, Seoul

Handok Investigational site 204, Seoul

Handok Investigational site 205, Seoul

Handok Investigational site 206, Seoul

Handok Investigational site 207, Seoul

Handok Investigational site 208, Yangsan